Showing results (101-110 of 3,952) with videos related to

Sort By:
Pageof 396
Science China. Life Sciences|August 18, 2020
Nucleoprotein phosphorylation site (Y385) mutation confers temperature sensitivity to influenza A virus due to impaired nucleoprotein oligomerization at a lower temperatureWeinan Zheng, Liang Cui, Minghui Li, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 30, 2025
Synergistic Material-Structure Engineering for Mid-Infrared Thermal Management in TextilesRuiyao Xu, Ziyuan Zhu, Hanyuan Zhang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 22, 2024
Excessive fatty acids activate PRMT5/MDM2/Drosha pathway to regulate miRNA biogenesis and lipid metabolismAijun Hou, Xiaoding Xu, Yu Zhang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 4, 2021
Cyclophilin A is a key positive and negative feedback regulator within interleukin-6 trans-signaling pathwayXiaohan Luan, Wenxian Yang, Xiaoyuan Bai, et al.
Frontiers in Cellular and Infection Microbiology|May 17, 2018
A Promising IFN-Deficient System to Manufacture IFN-Sensitive Influenza Vaccine VirusCan Chen, Wenhui Fan, Jing Li, et al.
Antiviral Research|May 27, 2023
Recombinant porcine interferon cocktail delays the onset and lessens the severity of African swine feverPengtao Jiao, Shuchao Wang, Wenhui Fan, et al.
Journal of Drug Targeting|February 5, 2024
Valeric acid reduction by chitosan oligosaccharide induces autophagy in a Parkinson's disease mouse modelRongsha Chen, Ke Li, Yinying Wang, et al.
International Immunopharmacology|November 14, 2020
Forkhead box O1-mediated ubiquitination suppresses RIG-I-mediated antiviral immune responsesZhenling Ma, Wenwen Zhang, Wenhui Fan, et al.
Food & Function|February 8, 2023
Baicalein alleviates non-alcoholic fatty liver disease in mice by ameliorating intestinal barrier dysfunctionChunyu Guo, Qingjun Li, Rihong Chen, et al.
Parkinsonism & Related Disorders|September 7, 2015
A randomized, double-blind, controlled trial of add-on therapy in moderate-to-severe Parkinson's diseaseShifu Zhao, Rongchuan Cheng, Jian Zheng, et al.
Pageof 396